- Vonoprazan met the primary endpoint for all three dose levels (10 mg, 20 mg, 40 mg) taken on-demand, demonstrating faster and sustained relief of episodic heartburn as compared to placebo (p
Phathom Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial Evaluating Vonoprazan for Non-Erosive Gastroesophageal Reflux Disease (NERD)
Watch Phathom Pharmaceuticals' latest callPhathom Pharmaceuticals (NASDAQ:PHAT) Q3 2026 Earnings Call · Replay · Oct 29Read the transcript of Phathom Pharmaceuticals (NASDAQ:PHAT) Q3 2026 Earnings CallPhathom Pharmaceuticals, Inc. on 6ix
Story so far
- Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
- Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints
Earlier from Phathom Pharmaceuticals
- Phathom Pharmaceuticals to Participate in the 4th Annual Evercore ISI HealthCONx Conference
- Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences
- Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates
- Phathom Pharmaceuticals Withdraws Public Offering
- Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock
Later from Phathom Pharmaceuticals
- Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Pipeline and Business Progress
- Phathom Pharmaceuticals Submits Vonoprazan NDA to FDA for the Treatment of Erosive Esophagitis
- Phathom Pharmaceuticals Announces Appointment of Molly Henderson as Chief Financial and Business Officer
- Phathom Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
- Phathom Pharmaceuticals Appoints Frank Karbe to its Board of Directors
Follow Phathom Pharmaceuticals into a list and get an email when it puts out news.
Follow Phathom Pharmaceuticals